Recent advances in cell-penetrating, non-peptide molecular carriers

International Journal of Pharmaceutics

Volumn 354, Issue 1-2, 2008, Pages 16-22

  Chung, Sung Kee ^a   Maiti, Kaustabh K ^a   Lee, Woo Sirl ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Blood brain barrier; Cell penetration; Molecular carrier vectors; Organelle selectivity; Tissue selectivity

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ARGININE; BETA CYCLODEXTRIN; CARBAMIC ACID DERIVATIVE; CARRIER PROTEIN; DENDRIMER; DNA; DOXORUBICIN; GUANIDINE; LIPOSOME; NEOMYCIN; NUCLEOTIDE DERIVATIVE; OLIGOCARBAMATE; PEPTIDASE; POLYAMIDOAMINE; POLYETHYLENEIMINE; POLYLYSINE; POLYMER; PROTEIN DERIVATIVE; SORBITOL; TOBRAMYCIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

BREAST CANCER; CELL MEMBRANE PERMEABILITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG INHIBITION; DRUG STRUCTURE; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; IN VIVO STUDY; LEUKEMIA; NEUROTOXICITY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; BIOLOGICAL AVAILABILITY; CELL MEMBRANE PERMEABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NUCLEOTIDES; PEPTIDES; PROTEINS;

EID: 40849124044     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.08.016     Document Type: Short Survey

References (48)

1. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
2. Alper J. Breaching the membrane. Science 296 (2002) 838-839
3. Brooks H., Lebleu B., and Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Deliv. Rev. 57 (2005) 559-577
4. Dawson V.L. Maiming mitochondria in familial ALS. Nat. Med. 9 (2004) 905-906
5. Dupont E., Joliet A., and Prochiantz A. In: Langel U. (Ed). Penetratins, in Cell-Penetrating Peptides; Processes and Applications (2002), CRC Press, Boca Raton 23-52
6. Elliott G., and O'Hara P. Intercellular trafficking and protein delivery by herpes-virus structural protein. Cell 88 (1997) 223-233
7. Fernandez-Carneado J., Van Gool M., Martos V., Castel S., Prados P., de Mendoza J., and Giralt E. Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria. J. Am. Chem. Soc. 127 (2005) 869-874
8. Ferrari A., Pellegrini V., Arcangeli C., Fittipaldi A., Giacca M., and Beltram F. Caveolae-mediated internalization of extracellular HIV-1 Tat fusion proteins visualized in real time. Mol. Ther. 8 (2003) 284-294
9. Futaki S. Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv. Drug Deliv. Rev. 57 (2005) 547-558
10. Futaki S., Suzuki S., Ohashi W., Yagami T., Tanaka S., Ueda K., and Sugiura Y.B. Arginine-rich peptides. J. Biol. Chem. 276 (2001) 5836-5840
11. Futaki S., Goto S., Suzuki T., Nakase I., and Sugiura Y. Structural variety of membrane permeable peptides. Curr. Protein Pept. Sci. 4 (2003) 87-96
12. Geueke B., Namoto K., Agarkova I., Perriad J.C., Kohler H.P., and Seebach D. ChemBioChem 6 (2005) 982-985
13. Goldberg M., and Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat. Rev. Drug Discov. 2 (2003) 289-295
14. Gupta B., Levchenko T.S., and Torchilin V.P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug. Deliv. Rev. 57 (2005) 637-651
15. Jo D., Liu D., Yao R., Collins R.D., and Hawiger J. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat. Med. 11 (2005) 892-898
16. Joliot A., and Prochiantz A. Transduction peptides: from technology to physiology. Nat. Cell Biol. 6 (2004) 189-196
17. Khalil I.A., Kogure K., Futaki S., and Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem. 281 (2006) 3544-3551
18. Kogure K., Moriguchi R., Sasaki K., Ueno M., Futaki S., and Harashima H. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J. Control. Release 98 (2004) 317-323
19. Kola I., and Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 3 (2004) 711-715
20. Lambert D.M. Rationale and applications of lipids as prodrug carriers. Eur. J. Pharm. Sci. 11 Suppl. 2 (2000) S15-S27
21. Lane N.N. Powerhouse of disease. Nature 440 (2006) 600-602
22. Langer R. Drugs on target. Science 293 (2001) 58-59
23. Luedtke N.W., Carmichael P., and Tor Y. Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginine. J. Am. Chem. Soc. 125 (2003) 12374-12375
24. Maiti K.K., Jeon O.Y., Lee W.S., Kim D.C., Kim K.T., Takeuchi T., Futaki S., and Chung S.K. Design, synthesis, and membrane translocation studies of inositol-based transporters. Angew. Chem. Int. Ed. 45 (2006) 2907-2912
25. Maiti K.K., Jeon O.Y., Lee W.S., and Chung S.K. Design, synthesis, and delivery properties of novel guanidine-containing molecular transporters built on dimeric inositol scaffolds. Chem. Eur. J. 13 (2007) 762-775
26. Maiti K.K., Lee W.S., Takeuchi T., Watkins C., Fretz M., Kim D.C., Futaki S., Jones A., Kim K.T., and Chung S.K. Novel guanidine-containing molecular transporters: sorbitol-based transporters show high intracellular selectivity toward mitochondria. Angew. Chem. Int. Ed. (2007) 5880-5884
27. Murphy J.E., Uno T., Hamer J.D., Cohen F.E., Dwarki V., and Zuckermann R.N. A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery. Proc. Nat. Acad. Sci. USA 95 (1998) 1517-1522
28. Prochiantz A. Protein transduction: from physiology to technology and vice versa. Adv. Drug Deliv. Rev. 57 (2005) 491-493
29. Ragin A.D., Morgan R.A., and Chmielewski J. Cellular import mediated by nuclear localization sequences. Chem. Biol. 9 (2002) 943-948
30. Rothbard J.B., Garlington S., Lin Q., Kirschberg T., Kreider E., McGrane P.L., Wender P.A., and Khavari P.A. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 6 (2000) 1253-1257
31. Rothbard J.B., Kreider E., Vandeusen C.L., Wright L., Wylie B.L., and Wender P.A. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J. Med. Chem. 45 (2002) 3612-3618
32. Rothbard J.B., Jessop T.C., and Wender P.A. Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv. Drug Deliv. Rev. 57 (2005) 495-504
33. Rousselle C.R., Smirnova M., Clair P., Lefauconnier J., Chavanieu -M., Calas A., Scherrmann B.J., and Temsamani -M.J. Enhanced delivery of doxorubicin into brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. J. Pharmacol. Exp. Therapeut. 296 (2001) 124-131
34. Rueping M., Mahajan Y., Sauer M., and Seebach D. Cellular uptake studies with β-peptides. ChemBiochem 3 (2002) 257-259
35. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
36. Torchilin V.P., Rammohan R., Weissig V., and Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery of even at low temperature and in the presence of metabolic inhibitors. Proc. Nat. Acad. Sci. USA 98 (2001) 8786-8791
37. Tunnemann G., Martin R.M., Haupt S., Patsch C., Edenhofer F., and Cardoso M.C. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J. 20 (2006) 1775-1784
38. Tyagi M., Rusnati M., Presta M., and Giacca M. Internalization of HIV-1 TAT requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276 (2001) 3254-3261
39. Umezawa N., Gelman M.A., Haigis M.C., Raines R.T., and Gellman S.H. Translocation of a β-peptide across cell membranes. J. Am. Chem. Soc. 124 (2002) 368-369
40. Vives E., and Lebleu B. In: Langel U. (Ed). The Tat-Derived Cell-Penetrating Peptide, in Cell-Penetrating Peptides; Processes and Applications (2002), CRC Press, Boca Raton 3-22
41. Vives E. Cellular uptake of the Tat peptide: an endocytosis mechanism following ionic interactions. J. Mol. Recog. 16 (2003) 265-271
42. Wadia J.S., and Dowdy S.F. Modulation of cellular function by TAT mediated transduction of full length proteins. Curr. Protein Pept. Sci. 4 (2003) 97-104
43. Wadia J.S., Stan R.V., and Dowdy S.F. Transducible TAT-HA fusogenic peptide enhanced escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 (2004) 310-315
44. Weissig V., Cheng S.-M., and D'Souza G.G.M. Mitochondrial pharmaceutics. Mitochondria 3 (2004) 229-244
45. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., and Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Nat. Acad. Sci. USA 97 (2000) 13003-13008
46. Wender P.A., Rothbard J.B., Jessop T.C., Kreider E.L., and Wylie B.L. Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery. J. Am. Chem. Soc. 124 (2002) 13382-13383
47. Wright L.R., Rothbard J.B., and Wender P.A. Guanidinium rich peptide transporters and drug delivery. Curr. Protein Pept. Sci. 4 (2003) 105-124
48. Zhou P., Wang M., Du L., Fisher G.W., Waggoner A., and Ly D.H. J. Am. Chem. Soc. 125 (2003) 6878-6879